Abstract:Background and Objective: The therapeutic level and dose of irradiation for the regional prevention of nasopharyngeal cancer (NPC) for patients with cervical lymph node involvement remains controversial. This study analyzed the effects of radiotherapy on cervical lymph nodes for the patients with stage-NO NPC. Methods: Between January 2002 and December 2004, 205 NPC patients with negative lymphadenopathy diagnosed by Imaging, were retrospectively analyzed. Before treatment, each patient underwent CT or MRI. Facial-cervical portals and 6-8 MV photons were used In radiotherapy. Doses applied were 60-80 Gy to the nasopharynx and 46-64 Gy to the neck without lymphadenopathy. Consecutive radiotherapy was performed employing conventional fractionation of 2 Gy/fractlon, once a day, for a total of five fractions per week. Chemotherapy was administered to 60 patients. Median follow-up was 44 months. The survival function was calculated according to the KaplanMeier method. A log-rank test was used to compare the differences in survival. The Cox proportional hazards model was used for multivariate analysis. A total of 205 patients with stage-NO NPC were divided Into an upper-neck irradiation group and an entire- neck group. Results: The 3-year overall survival rate (OS) was 92.9% and the 3-year disease-free survival rate (DFS) was 91.9%. A total of 88 patients received irradiation to the upper neck and 117 to the entire neck. The rate of regional failure for the upper-neck group and the entire-neck group were 2.27% and 0%, respectively (P > 0.05). The rates of regional failure in patients with T1-, T2-, T3- and T4-stage disease were 0%, 3.08%, 0%, and 0%, respectively (P > 0.05). The rates of regional failure in the patients both without and with local failure were 1.03% and 0%, respectively (P > 0.05). The 1- and 3-year OS for the upper-neck group were 97.7% and 94.2%, and the 1- and 3-year OS for the entire-neck group were 97.4% and 91.9% (P = 0.950). The 1- and 3-year DFS for the upper-neck group were 96.6% and 92.9%, and the 1- and 3-year DFS for the entire-neck group were 95.6% and 90.9% (P = 0.730). In multivariate analysis, sex (P = 0.039) and T stage (P = 0.004) were independent prognosis factors for patients with stage-NO NPC. Conclusions: Radiotherapy to the upper neck does not influence regional failure or long- term survival in the patients with stage-NO NPC. Radiotherapy to the upper neck (levels II, III, VA) is recommended for the patients with stage-NO NPC. Involvement of the parapharyngeal space, T stage, and the rates of local failure do not influence regional failure in these patients. Sex and T stage were independent prognosis factors for the patients with stage-NO NPC.

Surgery for the Recurrent and Persistent Lymph Node of Nasopharyngeal Carcinoma after Radiotherapy

Neck Dissection for Recurrent and Persistent Lymph Nodes of Nasopharyngeal Carcinoma after Radiotherapy： Effect and Choice

[Salvage surgery for neck recurrence or residue of nasopharyngeal carcinoma after primary radiotherapy]

The Surgical Treatment of Failure in Cervical Lymph Nodes after Radiotherapy for Nasopharyngeal Carcinoma: an Analysis of 83 Patients

Salvage Surgery for Neck Residue or Recurrence of Nasopharyngeal Carcinoma after Primary Radiotherapy: Options of Surgical Methods and Regions

Surgical treatment and prognosis of recurrent and radiotherapy insensitive nasopharyngeal carcinoma

Modified Radical Neck Dissection for Residual Neck Disease after Radiotherapy of Nasopharyngeal Carcinoma.

Surgery for Isolated Regional Failure in Nasopharyngeal Carcinoma after Radiation: Selective or Comprehensive Neck Dissection

Radiotherapy of cervical lymph nodes for the patients with stage-NO nasopharyngeal carcinoma

A combined microinvasive trans-submandibular and nasendoscopy surgical approach to dissect recurrent or radiotherapy-insensitive nasopharyngeal carcinoma

[Radiotherapy on Neck for Nasopharyngeal Carcinoma Patients with Negative Cervical Lymph Node].

Treatment Outcome of Nasopharyngeal Carcinoma with Retropharyngeal Lymph Nodes Metastasis Only and the Feasibility of Elective Neck Irradiation.

Salvage Endoscopic Nasopharyngectomy and Intensity-Modulated Radiotherapy Versus Conventional Radiotherapy in Treating Locally Recurrent Nasopharyngeal Carcinoma.

Research of Radiotherapy Dose on Suspicious Positive Lymph Nodes in Neck Negative Nasopharygneal Carcinoma Patients

Transcervical Endoscopic Retropharyngeal Lymph Node (RPLN) Dissection in Nasopharyngeal Carcinoma with RPLN Recurrence.

Selective neck dissection for neck residue of nasopharyngeal carcinoma: A prospective study

Analysis of Cervical Lymph Nodes Recurrence after Radiotherapy for Nasopharyngeal Carcinoma

[Salvage Surgical Operation Via Endoscopic Transnasal Approach for Local Persistent or Recurrent Nasopharyngeal Carcinoma].

Identifying Optimal Candidates for Postoperative Adjuvant Therapy among Regional Persistent/recurrent Nasopharyngeal Carcinoma Patients after Neck Dissection

Review in the surgical management for residual and recurrent neck lymph node of nasopharyngeal carcinoma after radiotherapy and chemotherapy

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma